1. Is Pfizer’s established drugs’ decline in China a canary in a coalmine? — Amgen biosimilar debut boosted by UnitedHealthcare coverage — Novartis CEO says FDA process could’ve been handled better — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. What happened a year ago this week in biopharma? Regeneron’s Eylea approval, Novartis’ new ethics czar, Vertex’s Kalydeco, and Opidvo’s SCLC approval click to review and read a current update of the big stories from one year ago
    Dismiss Notice

Tick Tick Tick

Discussion in 'Johnson & Johnson IT' started by anonymous, Jun 29, 2018 at 6:09 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    yes, that is the best question of them all. She is clueless and must have pictures. If you look at all the folks who have gone, she is not someone you would have expected to see standing in the end. Anyone have the scoop on what the real story is?
     
  2. anonymous

    anonymous Guest

    heard both SM and CD are out by Jan1 - can anyone confirm or is it just wishful thinking?
     
  3. anonymous

    anonymous Guest

    SM contract expires EOY, heard he is negotiating with New leadership...don’t know who the other person is
     
  4. anonymous

    anonymous Guest

    Who is MM? Why the hate?
     
  5. anonymous

    anonymous Guest

    Nice person, clueless leader. Has zero understanding of how the real world works, passes the buck constantly, has never rolled her sleeves up to get into the gritty details of actually doing the "work" since joining J&J.
     
  6. anonymous

    anonymous Guest

    and yet....she still has a job! While other more knowledgeable IT folks and better people leaders have been eliminated. What’s the story there?
     
  7. anonymous

    anonymous Guest

    Completely agree with the last two post. She was on the "acquiring" side of the acquisition. Kept her crony team whole except one and let the AS team go.
     
  8. anonymous

    anonymous Guest

    Stated June of 2018, to be vindicated feels so good .......
     
  9. anonymous

    anonymous Guest

    The new rumor is all of TS will be outsourced similar to what laverne did with the ITS folks in 2007-8. Game on bitches!
     
  10. anonymous

    anonymous Guest

    So what you’re really saying is that this too will be an epic failure? Because that’s what all of LC’s oursourcing has wound up being.
     
  11. anonymous

    anonymous Guest

    Of course it will fail. The point is the new CIO needs to have a radical plan and it will be the wholesale outsourcing of IT services including BUIT.

    J&J is a healthcare company and IT is a commodity. The advent of virtual data centers and SaaS for everything makes it easy to blow-up the majority of IT as we know it. Some jobs will move to the business, but at least 50% of IT positions will be eliminated in the next 2 yrs. Bank on it!